United States · FDA National Drug Code directory
Atovaquone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60687-534_415fac59-7480-cad1-e063-6394a90ad7ba
- Product NDC
- 60687-534
- Form
- SUSPENSION
- Composition / generic term
- Atovaquone
- Labeler
- American Health Packaging
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201021
- Source listing expiry
- 20261231
Source-listed ingredients
- ATOVAQUONE — 750 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TRAY in 1 CASE (60687-534-36) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-534-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40) · 60687-534-36
- 7 TRAY in 1 CASE (60687-534-78) / 6 CUP, UNIT-DOSE in 1 TRAY (60687-534-52) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40) · 60687-534-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →